T 2056/17 (Combination lacosamide-levetiracetam/UCB) of 03.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T205617.20211103
- Date of decision
- 3 November 2021
- Case number
- T 2056/17
- Petition for review of
- -
- Application number
- 13004798.8
- IPC class
- A61K 45/06A61K 31/55A61K 31/4015A61K 31/53A61K 38/04A61K 31/40A61K 31/195A61K 38/05A61K 31/4166A61K 31/165A61K 31/35A61P 25/08A61K 31/19B65D 81/32
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical composition comprising lacosamide and levetiracetam for use in the treatment of epilepsy
- Applicant name
- UCB Pharma GmbH
- Opponent name
- Helm AG
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 76(1)
- Keywords
- Main request and auxiliary request 1 - novelty of second medical use (no)
Auxiliary request 2 - subject-matter extends beyond content of earlier application (yes)
Auxiliary request 3 - no examination (reformatio in peius) - Catchword
- -
- Cited cases
- G 0009/92
- Citing cases
- T 1390/22
Order
For these reasons it is decided that:
The appeal is dismissed.